Lokken Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.22M | Sell |
5,419
-197
| -4% | -$154K | 1.63% | 18 |
|
|
2025
Q1 | $4.64M | Buy |
5,616
+1,510
| +37% | +$1.25M | 1.96% | 16 |
|
|
2024
Q4 | $3.17M | Sell |
4,106
-63
| -2% | -$48.6K | 1.37% | 18 |
|
|
2024
Q3 | $3.69M | Sell |
4,169
-30
| -0.7% | -$26.6K | 1.54% | 17 |
|
|
2024
Q2 | $3.8M | Sell |
4,199
-337
| -7% | -$305K | 1.79% | 15 |
|
|
2024
Q1 | $3.53M | Sell |
4,536
-224
| -5% | -$174K | 1.76% | 15 |
|
|
2023
Q4 | $2.77M | Hold |
4,760
| – | – | 1.57% | 15 |
|
|
2023
Q3 | $2.56M | Sell |
4,760
-4
| -0.1% | -$2.15K | 1.68% | 15 |
|
|
2023
Q2 | $2.23M | Sell |
4,764
-153
| -3% | -$71.8K | 1.46% | 18 |
|
|
2023
Q1 | $1.69M | Sell |
4,917
-95
| -2% | -$32.6K | 1.28% | 19 |
|
|
2022
Q4 | $1.83M | Buy |
5,012
+71
| +1% | +$26K | 1.45% | 20 |
|
|
2022
Q3 | $1.6M | Buy |
4,941
+1
| +0% | +$323 | 1.38% | 22 |
|
|
2022
Q2 | $1.6M | Sell |
4,940
-106
| -2% | -$34.4K | 1.3% | 20 |
|
|
2022
Q1 | $1.47M | Buy |
5,046
+40
| +0.8% | +$11.7K | 1.17% | 22 |
|
|
2021
Q4 | $1.38M | Buy |
5,006
+388
| +8% | +$107K | 0.99% | 24 |
|
|
2021
Q3 | $1.07M | Sell |
4,618
-124
| -3% | -$28.7K | 0.85% | 28 |
|
|
2021
Q2 | $1.09M | Buy |
4,742
+1
| +0% | +$229 | 0.88% | 27 |
|
|
2021
Q1 | $886K | Sell |
4,741
-419
| -8% | -$78.3K | 0.78% | 31 |
|
|
2020
Q4 | $871K | Buy |
+5,160
| New | +$871K | 0.8% | 28 |
|